Edris Badreddin's Form 4 filing
SpringWorks Therapeutics, Inc.SWTX · filed Jun 5, 2024
- Accession no.
- 0001104659-24-068673
- Filed
- Jun 5, 2024
- Trade date
- Jun 3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $801.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edris BadreddinCIK 0001786966 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Common Stock | SSaleDisposed | −11,772 | $39.40F2 | −$463,816.8 | 257,828 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −4,192 | $40.62F3 | −$170,279.04 | 253,636 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −3,651 | $41.38F4 | −$151,078.38 | 249,985 | Direct | |
| Jun 3, 2024 | Common Stock | SSaleDisposed | −385 | $42.04F5 | −$16,185.4 | 249,600 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.98 to $39.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.98 to $40.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.98 to $41.955. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.99 to $42.065. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.